|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-10S3
|
$176,626
|
$21,195
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Children's Oncology Group Chair's Grant
|
7U10CA098543-10
|
$26,733,729
|
$3,208,047
|
ADAMSON, PETER
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
$2,164
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$70,613
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
Children's Oncology Group Statistics and Data Center Grant
|
7U10CA098413-10
|
$5,792,621
|
$695,115
|
ANDERSON, JAMES
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
|
5R01CA159959-02
|
$596,488
|
$596,488
|
Arbeit, Jeffrey
|
WASHINGTON UNIVERSITY
|
|
|
Identifying a Hypoxia Inducible Factor target profile in Renal Cell Carcinoma tum
|
5F31CA154080-02
|
$34,547
|
$34,547
|
Arreola, Alexandra
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
$6,470
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
$29,530
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-09
|
$333,500
|
$66,700
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$3,549
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-22
|
$536,603
|
$10,732
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
|
Discovery of Molecular and Imaging Biomarkers in RCC patient-Derived Tumorgrafts
|
5F31CA159897-02
|
$34,547
|
$34,547
|
Bailey, Sean
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
$41,137
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
$13,772
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Biorepository
|
3U24CA114748-07S1
|
$697,714
|
$69,771
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
$624,645
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-07
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIABC011232
|
$306,950
|
$30,695
|
Barchi, Joseph
|
CCR (NCI)
|
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-15
|
$349,322
|
$10,480
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIABC010620
|
$90,730
|
$22,682
|
Bates, Susan
|
CCR (NCI)
|
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIABC010622
|
$226,824
|
$45,365
|
Bates, Susan
|
CCR (NCI)
|
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$8,210
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
|
The Gulf Coast MBCCOP
|
3U10CA128536-05S1
|
$391,891
|
$3,919
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
|
Iowa Oncology Research Association
|
2U10CA035101-27
|
$669,579
|
$20,087
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
|
ECOG Clinical Trials
|
5U10CA017145-37
|
$415,756
|
$4,158
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$223,292
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$1,131
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$1,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-19
|
$543,533
|
$16,306
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-24
|
$355,104
|
$3,551
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
Cancer and Leukemia Group B
|
3U10CA031946-31S1
|
$114,228
|
$3,427
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-27S1
|
$405,901
|
$4,059
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B
|
5U10CA031946-31
|
$7,759,618
|
$232,789
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-28
|
$2,286,202
|
$22,862
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIABC011470
|
$232,561
|
$81,396
|
Beutler, John
|
CCR (NCI)
|
|
|
Mechanism of Acquired Resistance to VEGF-R Antagonists in RCC
|
5K08CA138900-03
|
$169,560
|
$169,560
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
JHU ICMIC Program
|
5P50CA103175-07
|
$1,442,883
|
$28,858
|
Bhujwalla, Zaver
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-21
|
$258,854
|
$88,010
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
|
Identifying rare haplotype-environment interactions using Logistic Bayesian Lasso
|
1R03CA171011-01
|
$85,028
|
$85,028
|
Biswas, Swati
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$9,230
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-15
|
$487,632
|
$14,629
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
|
Identification of HIF-Regulated Oncogenic Mediators in Renal Cell Carcinoma
|
ZIABC011095
|
$115,347
|
$115,347
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics
|
ZIABC011123
|
$69,208
|
$34,604
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIABC011124
|
$276,834
|
$55,367
|
Bottaro, Donald
|
CCR (NCI)
|
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
2R01CA054498-21A1
|
$714,157
|
$714,157
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Laboratory of Translational Genomics_Brown
|
ZIA CP010201-10570
|
$464,398
|
$46,440
|
Brown, Kevin
|
DCEG (NCI)
|
|
|
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
|
5R01CA129387-05
|
$316,002
|
$158,001
|
Brugarolas, James
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Total relevant funding to Kidney Disease for this search: $51,591,343
|
